Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 3

Intravitreal Afl ibercept Treatment in Retinal Artery Macroaneurysm

Retinal Arter Makroanevrizmasında İntravitreal Afl ibersept Tedavisi

Pages
276–279
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anatomical, and functional improvement was achieved and no other complications were observed in follow-up period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Effi cacy of intravitreal afl ibersept injection is shown in a patient with retinal arterial macroaneurysm.
📊
Key Findings & Data:A 89-year-old woman presented with decreased visual acuity in the left eye.
💡
Conclusion & Impact:Anatomical, and functional improvement was achieved and no other complications were observed in follow-up period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Effi cacy of intravitreal afl ibersept injection is shown in a patient with retinal arterial macroaneurysm. A 89-year-old woman presented with decreased visual acuity in the left eye. Ophthalmoscopy, fl uorescein angiography and optical coherence tomography revealed retinal arterial macroaneurysm, macular exudation, and subretinal fl uid in the left eye. In our case, intravitreal afl ibercept injection was administered as treatment. Anatomical, and functional improvement was achieved and no other complications were observed in follow-up period.

Özet

Retinal arteriyel makroanevrizması olan bir hastada intravitreal afl ibersept enjeksiyonunun etkinliği gösterilmektedir. 89 yaşındaki kadın hasta sol gözde görme azalması şikayeti ile başvurdu. Oftalmoskopi, fl öresein anjiyografi si ve optik koherens tomografi ile sol gözde retinal arteriyel makroanevrizma, makulada eksüdasyon ve subretinal sıvı saptandı. Olgumuza tedavi olarak intravitreal afl iber- sept enjeksiyonu uygulandı. Anatomik ve fonksiyonel iyileşme sağlandı ve takiplerde herhangi yeni bir komplikasyon gelişmedi.

🔖

Cite This Article

CEBECİ, Z., KIR, N. (2018). Intravitreal Afl ibercept Treatment in Retinal Artery Macroaneurysm. Retina-Vitreus, Cilt: 27 - Sayı: 3, 276–279. https://ajindex.com/articles/304877

References (6)

  1. Pitkänen L, Tommila P, Kaarniranta K, et al. Retinal arterial mac- roaneurysms. Acta Ophthalmol. 2014;92:101-4.
  2. Lavin MJ, Marsh RJ, Peart S,et al. Retinal arterial macroaneurys- ms: a retrospective study of 40 patients. Br J Ophthalmol 1987;71: 817-25. Unlu N. Retinal arteryel makroanevrizma.Ret-Vit 2012;20:Ö zel Sayı:111-4.
  3. Battaglia Parodi M, Iacono P, Pierro L, et al. Subthreshold laser tre- atment versus threshold laser treatment for symptomatic retinal ar- terial macroaneurysm. Invest Ophthalmol Vis Sci. 2012;53:1783- 6. Pichi F, Morara M, Torrazza C, et al. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol. 2013;155:287-94.
  4. Cho HJ, Rhee TK, Kim HS, et al. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol. 2013;155:898-904.
  5. Erol MK, Dogan B, Coban DT, et al. Intravitreal ranibizumab therapy for retinal arterial macroaneurysm. Int J Clin Exp Med. 2015;8:11572-8. Kishore K. Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Afl ibercept Injection. Case Rep Ophthalmol. 2016;7:162-71.
  6. Sonmez K, Ozturk F, Ozcan PY. Treatment of multilevel macu- lar hemorrhage secondary to retinal arterial macroaneurysm with submacular tissue plasminogen activator. Eur J Ophthalmol. 2012;22:1026-31.